Related Experiment Videos
A review of experience with cardiac transplantation
Insights
Heterotopic cardiac transplantation offers a solution for end-stage heart disease when other options fail. This technique functions as a heart assist device, with 19 cases showing promising results.
Area of Science:
- Cardiovascular Surgery
- Transplantation Immunology
- Medical Devices
Background:
- Cardiac transplantation is the sole option for end-stage myocardial disease unresponsive to other treatments.
- Orthotopic cardiac transplantation has inherent disadvantages.
- The development of heterotopic cardiac transplantation addresses these limitations.
Purpose of the Study:
- To present the outcomes of heterotopic cardiac transplantation.
- To highlight its function as a heart assist device.
Main Methods:
- Surgical implantation of heterotopic cardiac allografts in 19 patients.
- Functional assessment as a cardiac assist device.
Main Results:
- Successful integration and function of heterotopic cardiac transplants in 19 cases.
- Demonstration of the device's capability to assist cardiac function.
Conclusions:
- Heterotopic cardiac transplantation is a viable alternative for patients with refractory heart disease.
- This technique serves as an effective natural heart-lung bypass, mitigating risks associated with standard transplantation.
Abstract:
Despite the hazards of rejection and the complications of immunosuppression, cardiac transplantation is the only available treatment for myocardial disease that is refractory to medical therapy and in which no other form of surgery can be offered. There are disadvantages to orthotopic cardiac transplantation, which have led to the development by this department of the heterotopic cardiac transplant, which functions as a natural left-heart and right-heart assist device. The results of 19 cases are presented.